ctcae, common terminology criteria for adverse events

treatment c1–inh, c1-esterase inhibitor fast, for angioedema subcutaneous treatment ffp, fresh frozen plasma fresh frozen plasma hae, hereditary angioedema hereditary angioedema iqr, interquartile range lmic, low- and middle-income country sa, south africa(n) sae, serious adverse event teae, treatment-emergent adverse event usa, united states of america usd, united states dollar wao, world allergy organisation amyotrophic lateral sclerosis crp, c-reactive protein %fvc, forced vital capacity 6-ohda, 6-hydroxydopamine 8-ohdg, 8-hydroxydeoxyguanosine